About
Plasmahep 100IU Injection contains human hepatitis B immunoglobulin. It is used to protect against hepatitis B virus infection in adults and children. Hepatitis B virus is a virus that damages your liver, and gradually the virus can stop the liver from working properly. This medicine is usually given if you have been accidentally exposed to blood from an infected person, and to newborn babies born to mothers having hepatitis B virus.It is also given if your previous hepatitis B vaccination has not worked, after sexual exposure to persons with infection, after a liver transplant, and if you are having kidney dialysis (waiting for a hepatitis B vaccination to be fully effective). Plasmahep 100IU Injection should not be used if you suffer from any blood disorders, which involve blood clotting or if you are known to have antibodies to immunoglobulin A.Talk to your doctor if you have high blood pressure, blood disorders, diabetes, recently had or about to have any vaccinations before taking Plasmahep 100IU Injection. It is normally given with hepatitis B vaccine. Advanced Therapy for Thromboembolic Risk ReductionPlasmahep 100IU Injection offers targeted antithrombin III replacement, crucial for patients predisposed to clot formation due to deficiency. Its administration helps prevent severe complications like DVT or pulmonary embolism in high-risk settings. As a biological product, it provides reliable, clinician-supervised support where timely intervention is necessary.
Simple Preparation and Administration ProcessThis medication comes as a lyophilized powder and must be reconstituted with the recommended solvent before intravenous injection. All steps, including dose calculation and administration, should be performed by healthcare professionals to ensure safety and therapeutic efficacy. Detailed instructions can be found in the accompanying product insert or provided by your physician.
Rigorous Storage and Handling GuidelinesTo maintain potency, Plasmahep 100IU Injection must be stored in a refrigerator at temperatures between 2C and 8C and must not be frozen. Always check the packaging for expiry information before use. Careful handling and adherence to storage requirements are vital for maximum effectiveness and patient safety.
FAQ's of Plasmahep 100IU Injection:
Q: How should Plasmahep 100IU Injection be used?
A: Plasmahep 100IU Injection is administered intravenously following reconstitution with the appropriate solvent. Only trained healthcare professionals should prepare and inject this product under prescription and strict medical supervision.
Q: What is the main indication for prescribing Plasmahep 100IU Injection?
A: This medication is indicated as antithrombin III replacement therapy, primarily for preventing deep vein thrombosis (DVT) and pulmonary embolism in patients with hereditary or acquired antithrombin III deficiency.
Q: When is Plasmahep 100IU Injection recommended for administration?
A: It is generally prescribed for adults or children at high risk of thromboembolic events, especially during surgical procedures or periods of increased clotting risk, as advised by a physician.
Q: Where should Plasmahep 100IU Injection be stored before use?
A: The vial must be stored in a refrigerator at 2C to 8C and should not be frozen. Proper storage conditions are crucial to ensure drug potency and safety.
Q: What is the process for preparing this injection before administration?
A: Before use, the lyophilized powder must be reconstituted with a suitable solvent, as directed in the product literature or by the attending healthcare provider. The solution should be administered intravenously soon after preparation.
Q: What are the main benefits of Plasmahep 100IU Injection?
A: By restoring antithrombin III levels, this injection significantly reduces the risk of serious blood clots in susceptible individuals, offering lifesaving protection against DVT and pulmonary embolism when monitored and administered correctly.